SPI Healthcare
3.592,83
PKT
+39,03
PKT
+1,10
%
Werbung
Analysen zu SPI Healthcare-Werten
Datum | Rating | Analyst | |
---|---|---|---|
21.06.05 | Novartis buy | Jyske Bank | |
17.06.05 | Novartis reduce | UBS | |
16.06.05 | Novartis neutral | Robert W. Baird | |
16.06.05 | Novartis | Weberbank | |
10.06.05 | Novartis halten | Fuchsbriefe | |
08.06.05 | Novartis neutral | HypoVereinsbank | |
07.06.05 | Novartis neutral | Bank Sarasin & Cie | |
06.06.05 | Sonova | Die Actien-Börse | |
06.06.05 | Novartis buy | Merrill Lynch | |
03.06.05 | Novartis | Der Aktionärsbrief | |
03.06.05 | Novartis neutral | Bank Sarasin & Cie | |
02.06.05 | Novartis above average | Caris & Company | |
01.06.05 | Novartis Above Average | Caris & Company | |
30.05.05 | Novartis buy | Jyske Bank | |
26.05.05 | Novartis | JRC | |
23.05.05 | Novartis | JRC | |
18.05.05 | Roche Overweight | JP Morgan | |
18.05.05 | Roche Buy | Sarasin Research | |
13.05.05 | Roche Outperform | Goldman Sachs | |
10.05.05 | Novartis Buy | Smith Barney Citigroup | |
04.05.05 | Roche Buy | Helvea | |
03.05.05 | Lonza Buy | Helvea | |
02.05.05 | Lonza Reduce | Sarasin Research | |
29.04.05 | Novartis Sector Perform | Vontobel | |
27.04.05 | Roche Outperform | Goldman Sachs | |
29.04.05 | Roche Sector Outperform | Vontobel | |
27.04.05 | Roche Overweight | JP Morgan | |
27.04.05 | Roche Buy | Helvea | |
27.04.05 | Roche Kaufen | Hamburger Sparkasse | |
26.04.05 | Straumann Outperform | Goldman Sachs | |
26.04.05 | Novartis Kaufen | Hamburger Sparkasse | |
25.04.05 | Straumann Sector Perform | Vontobel | |
22.04.05 | Novartis Outperform | Goldman Sachs | |
27.04.05 | Novartis Kaufen | NATIONAL-BANK | |
22.04.05 | Novartis Overweight | Lehman Brothers | |
22.04.05 | Novartis Hold | SEB | |
21.04.05 | Roche Outperform | Goldman Sachs | |
22.04.05 | Novartis Kaufen | Helaba Trust | |
21.04.05 | Roche Sector Outperform | Vontobel | |
21.04.05 | Novartis Akkumulieren | Independent Research |